CIK 0001479419 · Non-accelerated filer<br>Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270604595
- Phone
- 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | Rosen Howard B Director | Grant or award · Stock Option (right to buy) | +10,651 | 10,651 | ||
| 2023-06-22 | Rosen Howard B Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award | +5,856 | 8,394 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award | +1,100 | 9,494 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +7,808 | 7,808 | ||
| 2023-06-22 | PERRY GREGORY D Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-06-22 | Myers C. Daniel Director | Grant or award | +3,784 | 5,424 | ||
| 2023-06-22 | Myers C. Daniel Director | Grant or award | +1,100 | 6,524 | ||
| 2023-06-22 | Myers C. Daniel Director | Grant or award · Stock Option (right to buy) | +5,046 | 5,046 | ||
| 2023-06-22 | Myers C. Daniel Director | Grant or award · Stock Option (right to buy) | +2,500 | 2,500 | ||
| 2023-06-22 | KOVEN ANDREW I Director | Grant or award | +7,515 | 10,772 | ||
| 2023-06-22 | KOVEN ANDREW I Director | Grant or award | +1,400 | 12,172 | ||
| 2023-06-22 | KOVEN ANDREW I Director | Grant or award · Stock Option (right to buy) | +10,020 | 10,020 | ||
| 2023-06-22 | KOVEN ANDREW I Director | Grant or award · Stock Option (right to buy) | +3,150 | 3,150 | ||
| 2023-06-22 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award | +36,847 | 61,902 | ||
| 2023-06-22 | Kharabi Darius CHIEF BUSINESS OFFICER | Grant or award · Stock Option (right to buy) | +49,129 | 49,129 | ||
| 2023-06-22 | Trachtenberg Eric SEE REMARKS | Grant or award | +37,559 | 64,693 | ||
| 2023-06-22 | Trachtenberg Eric SEE REMARKS | Grant or award · Stock Option (right to buy) | +50,078 | 50,078 | ||
| 2023-06-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +36,144 | 62,763 | ||
| 2023-06-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +48,192 | 48,192 |
Page 6 of 12 · 236 trades